FindTrial
Sign In

Clopidogrel 75 mg

DRUG9 trials

Sponsors

University of North Carolina, Chapel Hill, University of Florida, Dong-A University, HK inno.N Corporation, Mazandaran University of Medical Sciences

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionChronic Coronary SyndromeCoronary Artery DiseaseDisease SusceptibilityHealthyIschemic StrokeTicagrelor

Phase 1

Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants
CompletedNCT03814642
HK inno.N CorporationHealthy
Start: 2019-01-21End: 2019-07-22Updated: 2019-10-21
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects
NCT06164834
HK inno.N CorporationHealthy
Start: 2023-12-05End: 2024-11-30Target: 48Updated: 2023-12-11

Phase 2

Clopidogrel Pharmacogenomics Project
CompletedNCT01097343
University of North Carolina, Chapel HillDisease Susceptibility
Start: 2010-03-31End: 2011-05-31Updated: 2017-12-12

Phase 3

Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
CompletedNCT02944123
Dong-A UniversityAcute Coronary Syndrome
Start: 2016-09-30End: 2020-06-30Updated: 2020-08-20
Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke
CompletedNCT04738097
Mazandaran University of Medical SciencesIschemic Stroke, Transient Ischemic Attack
Start: 2021-08-08End: 2023-10-15Updated: 2023-10-19

Phase 4

Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
CompletedNCT02567461
University of FloridaCoronary Artery Disease
Start: 2016-03-31End: 2018-03-15Updated: 2018-04-06
Optimal Dosage of Ticagrelor in Korean Patients With AMI
NCT05210595
Dong-A UniversityAcute Myocardial Infarction, Ticagrelor
Start: 2022-01-01End: 2023-12-31Target: 120Updated: 2022-01-27
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
RecruitingNCT06821191
University of FloridaCoronary Artery Disease
Start: 2025-03-10End: 2027-01-07Target: 78Updated: 2025-04-15
Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease
Not yet recruitingNCT07080684
University of MessinaChronic Coronary Syndrome
Start: 2025-12-01End: 2027-09-30Target: 1000Updated: 2025-07-23

Related Papers

Ticagrelor plus aspirin vs clopidogrel plus aspirin in mild non-cardioembolic ischemic stroke: A protocol of a randomized, controlled, active comparator arm, outcome assessor blind, feasibility study
Neurology Asia2023-09-01